Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand [Yahoo! Finance]
Ascendis Pharma A/S - American Depositary Shares (ASND)
Last ascendis pharma a/s - american depositary shares earnings: 11/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ascendispharma.com
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . In the quarter the fund returned 5.77% (net), compared to a 7.58% return for the Russell 2000 Growth Index. Despite a decline in many equity markets in January, they rebounded over the following two months, resulting in a robust 2024 first quarter. In addition, please check the fund's top five holdings to know its best picks in 2024. TimesSquare Capital U.S. Small Cap Growth Strategy highlighted stocks like Ascendis Pharma A/S (NASDAQ: ASND ), in the first quarter 2024 investor letter. Ascendis Pharma A/S (NASDAQ:ASND) is a biopharmaceutical company. The one-month return of Ascendis Pharma A/S (NASDAQ:ASND) was -7.26%, and its shares gained 31.50% of their value over the last 52 weeks. On June 20, 2024, Ascendis Pharma A/S (NASDAQ:ASND) stock closed at $121.62 per share with a market capitalization of $6.947 billion. TimesSquare Capital U.S. Small Cap Growth Strategy stated the following regarding Ascendis Pharma A/S (NASDAQ:ASND) in i
Show less
Read more
Impact Snapshot
Event Time:
ASND
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASND alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASND alerts
High impacting Ascendis Pharma A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ASND
News
- Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsightPR Newswire
- Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsightPR Newswire
- Citi's ‘Catalyst Watch' list of U.S. stocks for crowding analysis [Seeking Alpha]Seeking Alpha
- Ascendis Pharma A/S (NASDAQ: ASND) had its price target raised by analysts at Bank of America Co. from $175.00 to $191.00. They now have a "buy" rating on the stock.MarketBeat
- Ascendis Pharma A/S Announces Pricing of Public Offering of ADSsGlobeNewswire
ASND
Earnings
- 9/3/24 - Miss
ASND
Sec Filings
- 9/27/24 - Form 6-K
- 9/23/24 - Form 6-K
- 9/20/24 - Form 424B5
- ASND's page on the SEC website